Spire Edinburgh Hospitals introduce advanced new treatment to patients with enlarged prostate or benign prostatic hyperplasia (BPH)

First hospitals in Scotland to offer minimally invasive aquablation therapy with significant reduction of side effects typically associated with alternative BPH treatment

Spire Edinburgh Hospitals have introduced aquablation therapy for the treatment of enlarged prostates or benign prostatic hyperplasia. Spire Edinburgh Hospitals have already treated seven patients with aquablation therapy and are currently the only hospitals in Scotland to offer this.

Aquablation therapy is an advanced, minimally invasive treatment for BPH that combines imaging and robotic technology to guide a heat-free waterjet for precise tissue removal. This provides long-lasting relief to benign prostatic hyperplasia¹ – one of the most common health complications faced by men over the age of 50.

One of the most important benefits of aquablation therapy over alternative BPH treatments, is that it will improve the preservation of continence and sexual function for patients. Advanced software and robotics allows the surgeon to accurately target diseased tissue before using a heat-free water jet to remove only the targeted tissue.

The most common complications with alternative surgical solutions are continence, and issues with erections and ejaculation.

Clinical studies have shown preserved continence and erection function in all men who have received aquablation therapy, while 90% retained their ejaculatory function, delivering a considerable reduction and low incidence of irreversible complications.

Patients can also expect long-lasting relief from BPH symptoms – studies have again indicated significant improvements for up to five years following the procedure.

The recovery process for aquablation therapy is also more comfortable, with patients being able to leave the hospital without a catheter.

Professor Alan McNeill, Consultant Urologist at Spire Edinburgh Hospitals, said: “‘I am delighted to be involved in bringing ablation therapy to patients in Scotland at Spire Murrayfield Hospital.

“Aquablation adds to the options available for patients to choose, and I believe offers advantages in particular to men with larger prostates, and in those who wish to preserve ejaculatory function.”